H.C. Wainwright Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $62

Moomoo NewsNov 4 06:31 ET · Ratings

Promising Clinical Trial Results and Strategic Combination Bolster Buy Rating for Revolution Medicines

TipRanksNov 4 06:26 ET · Ratings

Earnings Preview: RVMD to Report Financial Results Post-market on November 06

Moomoo NewsOct 31 21:00 ET

Unusual Options Activity: QRVO, DECK and Others Attract Market Bets, QRVO V/OI Ratio Reaches 333.3

Moomoo NewsOct 30 11:30 ET

Barclays Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsOct 29 03:32 ET · Ratings

Guggenheim Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $82

Moomoo NewsOct 28 10:31 ET · Ratings